drugset / Trial / NCT05473234

Azithromycin for Severe Acute Malnutrition in CMAM, Nigeria

NCT05473234

RandomizedParallel-groupSingle-blindTreatment

Summary

This randomized controlled trial is designed to determine the effect of administration of azithromycin compared to amoxicillin as part of the treatment of uncomplicated severe acute malnutrition (SAM) in children aged 6-59 months on weight gain and nutritional recovery. The investigators will randomize children presenting to Taimaka-run nutritional programs at health centers in Gombe State, Nigeria to a single dose of oral azithromycin or a short course of oral amoxicillin upon admission into the program. Apart from the administration of antibiotics, all children will receive standard outpatient treatment for uncomplicated SAM as specified in the guidelines of the government of Nigeria, which includes therapeutic feeding with ready-to-use therapeutic food (RUTF). Enrolled children will be followed weekly at each routine clinic follow-up visit up until nutritional recovery. All enrolled children will return for a final study visit at 8 weeks following enrollment. Anthropometric and vital status data will be collected at each follow-up visit. Weight gain and nutritional recovery over the 8-week study period will be compared by arm as a primary outcome and at 12 weeks as a secondary outcome.

Timeline

Start
2022-10-06
Primary completion
2023-11-29
Completion
2023-11-29

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amoxicillin Other / unclassified 15 mg/kg Oral
Subject Azithromycin Small molecule 20 mg/kg Oral